Guolin Ye

414 total citations
21 papers, 296 citations indexed

About

Guolin Ye is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Guolin Ye has authored 21 papers receiving a total of 296 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cancer Research, 10 papers in Molecular Biology and 10 papers in Oncology. Recurrent topics in Guolin Ye's work include Breast Cancer Treatment Studies (9 papers), MicroRNA in disease regulation (5 papers) and HER2/EGFR in Cancer Research (4 papers). Guolin Ye is often cited by papers focused on Breast Cancer Treatment Studies (9 papers), MicroRNA in disease regulation (5 papers) and HER2/EGFR in Cancer Research (4 papers). Guolin Ye collaborates with scholars based in China, India and France. Guolin Ye's co-authors include Ruilin Pan, Xiaosong Chen, Kunwei Shen, Dan Zhou, Peixian Chen, Weige Tan, Yingsong Wu, Zhiwei Guo, Xuexi Yang and Kejin Wu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Guolin Ye

21 papers receiving 292 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guolin Ye China 10 153 141 114 37 35 21 296
Xuhui Guo China 10 93 0.6× 188 1.3× 130 1.1× 54 1.5× 19 0.5× 26 311
Min‐Er Zhong China 8 92 0.6× 118 0.8× 101 0.9× 54 1.5× 52 1.5× 27 269
Liantao Guo China 7 76 0.5× 92 0.7× 121 1.1× 55 1.5× 42 1.2× 14 266
Spyros Tsavachidis United States 10 104 0.7× 196 1.4× 75 0.7× 49 1.3× 32 0.9× 16 330
Weizhu Wu China 12 141 0.9× 152 1.1× 65 0.6× 33 0.9× 17 0.5× 21 275
Rohaizak Muhammad Malaysia 11 92 0.6× 157 1.1× 73 0.6× 47 1.3× 57 1.6× 36 382
Tsunehisa Nomura Japan 9 80 0.5× 121 0.9× 137 1.2× 37 1.0× 25 0.7× 33 292
Zhouyu Li China 11 102 0.7× 158 1.1× 41 0.4× 32 0.9× 32 0.9× 31 276
Xiu-Zhi Zhu China 7 130 0.8× 86 0.6× 183 1.6× 96 2.6× 38 1.1× 13 310
Samira Kamrudin United States 3 124 0.8× 63 0.4× 156 1.4× 48 1.3× 29 0.8× 6 278

Countries citing papers authored by Guolin Ye

Since Specialization
Citations

This map shows the geographic impact of Guolin Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guolin Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guolin Ye more than expected).

Fields of papers citing papers by Guolin Ye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guolin Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guolin Ye. The network helps show where Guolin Ye may publish in the future.

Co-authorship network of co-authors of Guolin Ye

This figure shows the co-authorship network connecting the top 25 collaborators of Guolin Ye. A scholar is included among the top collaborators of Guolin Ye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guolin Ye. Guolin Ye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Li, Hong, Tingting Li, Shu‐Qing Yang, et al.. (2024). Organoid forming potential as complementary parameter for accurate evaluation of breast cancer neoadjuvant therapeutic efficacy. British Journal of Cancer. 130(7). 1109–1118. 2 indexed citations
3.
He, Tiancheng, Kun Zhang, Jia‐Wei Lin, et al.. (2023). Tumor-Targeting Extracellular Vesicles Loaded with siS100A4 for Suppressing Postoperative Breast Cancer Metastasis. Cellular and Molecular Bioengineering. 16(2). 117–125. 10 indexed citations
4.
Liu, Yuan, et al.. (2023). Nuclear transport maintenance of USP22-AR by Importin-7 promotes breast cancer progression. Cell Death Discovery. 9(1). 211–211. 3 indexed citations
5.
6.
Zhou, Dan, Kairong Lin, Juntao Gao, et al.. (2022). Single-cell and spatial transcriptome analyses revealed cell heterogeneity and immune environment alternations in metastatic axillary lymph nodes in breast cancer. Cancer Immunology Immunotherapy. 72(3). 679–695. 26 indexed citations
7.
Niu, Yingjie, Fan Zhang, Dong Chen, et al.. (2022). A comparison of Chinese multicenter breast cancer database and SEER database. Scientific Reports. 12(1). 10395–10395. 7 indexed citations
8.
Yang, Xu, Bo‐Wei Han, Zhiwei Guo, et al.. (2021). Association between the nucleosome footprint of plasma DNA and neoadjuvant chemotherapy response for breast cancer. npj Breast Cancer. 7(1). 35–35. 14 indexed citations
9.
Li, Lin, Xiang-Ming Zhai, Zhiwei Guo, et al.. (2021). A plasma-derived extracellular vesicle mRNA classifier for the detection of breast cancer. Gland Surgery. 10(6). 2002–2009. 9 indexed citations
10.
11.
Yu, Yunfang, Huangming Hong, Yongjian Chen, et al.. (2021). Clinical Evidence for Locoregional Surgery of the Primary Tumor in Patients with De Novo Stage IV Breast Cancer. Annals of Surgical Oncology. 28(9). 5059–5070. 9 indexed citations
12.
Lin, Li, Xiang-Ming Zhai, Xuexi Yang, et al.. (2021). Plasma-Derived Extracellular Vesicles Circular RNAs Serve as Biomarkers for Breast Cancer Diagnosis. Frontiers in Oncology. 11. 752651–752651. 23 indexed citations
13.
Han, Bo‐Wei, Qing Liu, Xu Yang, et al.. (2021). Noninvasive discrimination of benign and malignant breast lesions using genome-wide nucleosome profiles of plasma cell-free DNA. Clinica Chimica Acta. 520. 95–100. 4 indexed citations
14.
Ye, Guolin, et al.. (2020). Circ_DCAF6 potentiates cell stemness and growth in breast cancer through GLI1-Hedgehog pathway. Experimental and Molecular Pathology. 116. 104492–104492. 26 indexed citations
15.
Ye, Guolin, et al.. (2020). miR-34a Reverses Doxorubicin Resistance in Breast Cancer. Journal of Biomaterials and Tissue Engineering. 10(12). 1820–1826. 1 indexed citations
16.
Pan, Ruilin, et al.. (2019). <p>BCL11A enhances stemness and promotes progression by activating Wnt/&beta;-catenin signaling in breast cancer</p>. Cancer Management and Research. Volume 11. 2997–3007. 31 indexed citations
17.
Pan, Zihao, Kai Chen, Peixian Chen, et al.. (2018). Development of a nomogram to predict overall survival among non-metastatic breast cancer patients in China: a retrospective multicenter study. SHILAP Revista de lepidopterología. 1(1). 18–24. 3 indexed citations
18.
Zhou, Dan, et al.. (2017). Inhibitory effects of pigment epithelium-derived factor on epithelial-mesenchymal transition, migration and invasion of breast cancer.. PubMed. 10(10). 10593–10602. 3 indexed citations
19.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xuhui Guo Breakdown of academic impact, for papers by Min‐Er Zhong Breakdown of academic impact, for papers by Liantao Guo Breakdown of academic impact, for papers by Spyros Tsavachidis Breakdown of academic impact, for papers by Weizhu Wu Breakdown of academic impact, for papers by Rohaizak Muhammad Breakdown of academic impact, for papers by Tsunehisa Nomura Breakdown of academic impact, for papers by Zhouyu Li Breakdown of academic impact, for papers by Xiu-Zhi Zhu Breakdown of academic impact, for papers by Samira Kamrudin
Rankless by CCL
2026